甘油 (Glycyrrhiza pallidiflora) 聚糖通过保护肠道屏障的完整性来改善DSS诱导的大肠炎
Dandan Zeng1, Weijie Ren1, Bo Zhao1
1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Cell biochemistry and biophysics
|May 9, 2025
概括
草甘 (Glycyrrhiza pallidiflora) 聚糖 (GPP) 通过减少结肠损伤和改善肠炎,有效地改善小鼠的性结肠炎 (UC). 这项研究为基于天然产品的UC疗法提供了基础.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
- 胃肠病学 胃肠病学
背景情况:
- 性结肠炎 (UC) 是一种异常性炎症性肠病.
- 甘花花粉多糖 (GPP) 是UC的潜在治疗剂.
- 在UC中GPP的精确治疗机制尚不清楚.
研究的目的:
- 为了研究GPP对硫酸盐 (DSS) 诱导的UC的小鼠模型的治疗效果.
- 为了确定GPP的最佳提取和含量,用于UC治疗.
- 阐明GPP在实验性结肠炎中的改善机制.
主要方法:
- 建立了一个DSS诱导的UC小鼠模型.
- 使用超声波辅助提取提取并优化GPP含量.
- 给UC小鼠使用不同剂量的GPP (100, 200, 300 mg/kg).
- 通过监测体重减轻,疾病活动指数 (DAI) 和结肠损伤来评估治疗效果.
主要成果:
- 在UC小鼠中,GPP的使用延迟了体重减轻.
- GPP显著降低了DAI得分,表明疾病严重程度下降.
- 在DSS诱导的UC模型中,GPP治疗减少了结肠损伤和改善了肠炎.
- 优化的GPP提取产生了25.66%的含量.
结论:
- GPP在性结肠炎中显示出显著的治疗潜力.
- GPP对DSS诱导的肠炎和结肠损伤具有保护作用.
- 这些发现支持在UC管理中使用天然产品,如GPP.
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
Drugs for Treatment of Ulcerative Colitis in IBD
104
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
104
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
241
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
241
Chronic Bowel Disorders: Introduction
319
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
319
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
325
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
325


